Evauation of usefulness of clopidogrel bisulfate against ischemic cerebrovascular disorders
Not Applicable
- Conditions
- acunar stroke
- Registration Number
- JPRN-UMIN000006870
- Lead Sponsor
- Masafumi Ihara
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients involved in other interventional study/trials 2) Patients treated with cancer, infarction, or febrile disease 3) Patients with atherothrombotic infarction or cardiogenic embolism 4) Patients who have contraindications to clopidogrel written in a package leaflet 5) Patients who have already received clopidogrel 6) Patients who have already received two types of antiplatelet agents or anticoagulants 7) Patients who have already received t-PA 8) Patients who had surgery within 30 days
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mRS score at 90 days
- Secondary Outcome Measures
Name Time Method Cardiovascular event Hemorrhagic compication Other functional outcome